FDA Comment Deadline: Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development

Sunday, March 29, 2020 - 11:45pm

The Food and Drug Administration (FDA) is seeking comments to accompany the public meeting titled “FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development.” Developing a treatment for a rare disease can present unique challenges. The goal of this meeting is to obtain stakeholder’s perspectives on challenges and solutions in rare disease product development and identify commonalities that can support product development across a variety of rare diseases. For more information on meeting content, please see this FDA draft agenda.

Members of the public may submit comments online at Regulations.gov, or by mail. More information is available at this FDA website.